Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
about
Vaccines for malaria: how close are we?Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigensNatural selection maintains a stable polymorphism at the circumsporozoite protein locus of Plasmodium falciparum in a low endemic areaEnhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine.Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein.Induction of protective immune responses by immunization with linear multiepitope peptides based on conserved sequences from Plasmodium falciparum antigensCircumsporozoite protein genes of malaria parasites (Plasmodium spp.): evidence for positive selection on immunogenic regionsAntibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivoMultiple antigen peptide vaccines against Plasmodium falciparum malariaIn vivo testing of subunit vaccines against malaria sporozoites using a rodent system.Isolation and characterization of expression cDNA clones encoding antigens of Onchocerca volvulus infective larvae.Synthetic gene construct expressing a repeated and highly immunogenic epitope of the Plasmodium falciparum antigen Pf155.Theoretically determined three-dimensional structure for the repeating tetrapeptide unit of the circumsporozoite coat protein of the malaria parasite Plasmodium falciparum.Induction of humoral immune response against Plasmodium falciparum sporozoites by immunization with a synthetic peptide mimotope whose sequence was derived from screening a filamentous phage epitope libraryAntibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite iRabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion.Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in miceGenetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.Active and passive immunization against Plasmodium yoelii sporozoitesLiposomal malaria vaccine in humans: a safe and potent adjuvant strategy.The efficiency of sporozoite transmission in the human malarias, Plasmodium falciparum and P. vivax.Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrierPlasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies.Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides.Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparumCD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea.Heteroduplex stabilities in highly repetitive DNA. An hypothesis for the polymorphism of Plasmodium parasite antigenic response.Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection.Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection.Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32).Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans.ELISA method for detecting Plasmodium falciparum circumsporozoite antibody.Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells.Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.Synthetic peptides from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium knowlesi recognize the human hepatoma cell line HepG2-A16 in vitro.
P2860
Q27024344-5887330B-851F-4FFF-B15B-DE1116BCE1D2Q28304173-2F5901EC-184A-4884-B4F3-804FF371DD3AQ33563581-9CFC8577-07EA-48D1-B2A2-A5CFB68BC7B2Q33577093-B1EC3C66-5B49-4A01-A8B8-2A7E249AB7FEQ33599748-176BFF43-78EA-471A-9812-8591B172DBBAQ33756304-EAC79488-F063-4517-B461-0DEA4825F3DBQ33957574-9F7EA4DA-2924-41AB-8C4D-7CF46B67364FQ34004839-E4F69B00-F8AB-4AE6-A6FB-7C1017FCF90EQ34290800-3FB0BEFC-E54D-4ABE-B4A0-E80B8D9FA866Q34373653-5D03542B-AF0A-49FA-894C-005710E2F37BQ34557734-F36CC555-CB89-4E0A-9687-4CF4F99C53DBQ34602484-1290909C-E3C8-4E93-A50C-5CC11255DFE3Q34634916-FA9CD19E-D0F0-4F04-B234-6BADC55A782EQ35392822-4FD9AF2B-F9EA-43DB-9744-22DA9C2BE081Q35498349-E35998C3-1EF0-4BEF-BAE7-677054F1549CQ35590960-08D8C7F2-A55D-425D-A2E0-51B4BD61D08EQ35914430-BCFB37FA-3BF5-4BBA-9678-EB99BD7FC68FQ36352284-1B3D67B9-3C4F-4844-8B71-589F5B72E5DAQ36668561-C2A2D463-D746-41C1-8F5B-D416B42442FAQ36773737-C45F40EE-EBC0-4428-8837-3057262C33A2Q36799301-EB99598D-3813-449B-B0B4-DA5A2E502B71Q36944687-CC8A1965-12E8-4F83-916C-48834AAE58E3Q37007738-BC61D0D0-EECF-47FB-B93E-5DA11B5067C7Q37028297-E39AAD78-6262-45BF-B4A2-7604FBF720F0Q37134841-9C69148E-8E3D-44A0-8F13-901E65092308Q37313879-F33454D1-47D7-4F34-A6C8-441B03548ADEQ37392892-5DE4F156-379A-4677-BF0B-22E628EEFDECQ37483705-8AC91B7B-BE40-4DD1-9E29-93DAD6635D94Q39491568-A4299186-C980-438D-A809-6F984B96207AQ39727956-436CAC8B-77E4-4B15-BBBF-0D2DC3394709Q40157659-A38F62DB-EEB7-4BB1-AD9C-8D5E91C1CC1EQ40165125-D5BA07C8-255D-4E32-A3DB-3BEC03FB743CQ40193241-915F9F8C-D170-46B6-8EB8-647403D2D294Q40205403-A2C6AC39-4323-4980-BA33-C33C89518D14Q40207828-955A728E-932E-4101-B0F6-189E0FA95AFBQ40428421-50C57EDF-9C99-45CF-A0AF-12EBA1F2771BQ41200573-82B3F4C5-F7F3-4864-9E4C-F99010F50BDDQ41368217-2E686B50-2C05-48D7-BC24-FE5BFFBDE189Q42126049-593A909B-9CD3-4954-B9D5-2919C9B5A092Q42938628-83502B4E-4F02-4F67-BE80-03CFE16D50EF
P2860
Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Immunogenicity of synthetic pe ...... tein of Plasmodium falciparum.
@en
Immunogenicity of synthetic pe ...... tein of Plasmodium falciparum.
@nl
type
label
Immunogenicity of synthetic pe ...... tein of Plasmodium falciparum.
@en
Immunogenicity of synthetic pe ...... tein of Plasmodium falciparum.
@nl
prefLabel
Immunogenicity of synthetic pe ...... tein of Plasmodium falciparum.
@en
Immunogenicity of synthetic pe ...... tein of Plasmodium falciparum.
@nl
P2093
P356
P1433
P1476
Immunogenicity of synthetic pe ...... tein of Plasmodium falciparum.
@en
P2093
Beaudoin RL
Hollingdale MR
Rothbard J
Schneider I
Williams JS
P304
P356
10.1126/SCIENCE.2988126
P407
P577
1985-05-01T00:00:00Z